Comparison of hemostatic dressings for superficial wounds using a new spectrophotometric coagulation assay

[1]  A. Halim,et al.  Glycoprotein IIb/IIIa and P2Y12 Induction by Oligochitosan Accelerates Platelet Aggregation , 2014, BioMed research international.

[2]  M. Weinstein,et al.  More americans living longer with cardiovascular disease will increase costs while lowering quality of life. , 2013, Health affairs.

[3]  M. Than,et al.  Do Functional Keratin Dressings Accelerate Epithelialization in Human Partial Thickness Wounds? A Randomized Controlled Trial on Skin Graft Donor Sites , 2013, Eplasty.

[4]  L. Lin,et al.  Comparison of regenerated and non-regenerated oxidized cellulose hemostatic agents , 2013, European Surgery.

[5]  H. Schumacher,et al.  Collagen hemostat significantly reduces time to hemostasis compared with cellulose: COBBANA, a single-center, randomized trial. , 2013, American journal of surgery.

[6]  R. de Bree,et al.  Randomized clinical trial of donor‐site wound dressings after split‐skin grafting , 2013, The British journal of surgery.

[7]  W. Cao,et al.  Zeolite-based hemostat QuikClot releases calcium into blood and promotes blood coagulation in vitro , 2013, Acta Pharmacologica Sinica.

[8]  D. Ubbink,et al.  Topical haemostatic agents for skin wounds: a systematic review , 2011, BMC surgery.

[9]  J. Differding,et al.  Advanced hemostatic dressings are not superior to gauze for care under fire scenarios. , 2011, The Journal of trauma.

[10]  L. DiPietro,et al.  Factors Affecting Wound Healing , 2010, Journal of dental research.

[11]  H. Schumacher,et al.  A randomized, controlled, prospective trial to evaluate the haemostatic effect of Lyostypt versus Surgicel in arterial bypass anastomosis: "COBBANA" trial , 2009, Trials.

[12]  H Frederick Frasch,et al.  Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.

[13]  Michael A Dubick,et al.  Comparison of new hemostatic granules/powders with currently deployed hemostatic products in a lethal model of extremity arterial hemorrhage in swine. , 2009, The Journal of trauma.

[14]  S. Samudrala.  Topical hemostatic agents in surgery: a surgeon's perspective. , 2008, AORN journal.

[15]  G. Stucky,et al.  Metal oxide surface charge mediated hemostasis. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[16]  G. Bowlin,et al.  Comparison of a new hemostatic agent to current combat hemostatic agents in a Swine model of lethal extremity arterial hemorrhage. , 2007, The Journal of trauma.

[17]  M. Aguilar,et al.  Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No History of Stroke or Transient Ischemic Attacks , 2008 .

[18]  P. Rhee,et al.  Testing of modified zeolite hemostatic dressings in a large animal model of lethal groin injury. , 2006, The Journal of trauma.

[19]  Stephen S. Cha,et al.  Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence , 2006, Circulation.

[20]  J. Holcomb,et al.  Comparison of hemorrhage control agents applied to lethal extremity arterial hemorrhages in swine. , 2005, The Journal of trauma.

[21]  Paul J. Harrison,et al.  Platelet function analysis. , 2005, Blood reviews.

[22]  C. Weiss,et al.  Effects of vitamin K antagonist phenprocoumon on activated partial thromboplastin time measurement of direct thrombin inhibitors , 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[23]  G. Mensah,et al.  Increasing Trends in Hospitalization for Atrial Fibrillation in the United States, 1985 Through 1999: Implications for Primary Prevention , 2003, Circulation.

[24]  E. Fu,et al.  Chitosan enhances platelet adhesion and aggregation. , 2003, Biochemical and biophysical research communications.

[25]  D. Walsh,et al.  Oxidized cellulose dressings for persistent bleeding from a superficial malignant tumor , 2002, The American journal of hospice & palliative care.

[26]  A. Budzynski.  Chromogenic Substrates in Coagulation and Fibrinolytic Assays , 2001 .

[27]  M. Ågren,et al.  A fibre‐free alginate dressing in the treatment of split thickness skin graft donor sites , 1998, Journal of the European Academy of Dermatology and Venereology : JEADV.

[28]  David Hallac,et al.  Comparative efficacy of topical hemostatic agents in a rat kidney model. , 1992, American journal of surgery.

[29]  D. Long,et al.  Use of microfibrillar collagen as a topical hemostatic agent in brain tissue. , 1977, Journal of neurosurgery.

[30]  K. Kısmet,et al.  Effects of Ankaferd Blood Stopper and calcium alginate in experimental model of hepatic parenchymal bleeding. , 2015, Bratislavske lekarske listy.

[31]  F. Godinez,et al.  An alternative hemostatic dressing: comparison of CELOX, HemCon, and QuikClot. , 2008, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[32]  Richard A. Harris,et al.  Effect of a chitosan-based hemostatic dressing on blood loss and survival in a model of severe venous hemorrhage and hepatic injury in swine. , 2003, The Journal of trauma.

[33]  J. Krüger.  [Hemostasis in neurosurgical operations. A comparative study between collagen fleece (Lyostypt) and a gelatine sponge (Marbagelan)]. , 1992, Zentralblatt fur Neurochirurgie.